×
Home Current Archive Editorial board
News Contact
Original article

This is an early access version

Evaluation of risk factors for metabolic syndrome in epileptic patients in Palembang, Indonesia: a hospital-based and case-control study

By
Sri Handayani Orcid logo ,
Sri Handayani
Contact Sri Handayani

Biomedical Doctoral Study Program, Faculty of Medicine, Universitas Sriwijaya , Palembang , Indonesia

Department of Neurology, Faculty of Medicine, Universitas Sriwijaya , Palembang , Indonesia

Radiyati Umi Partan Orcid logo ,
Radiyati Umi Partan

Biomedical Doctoral Study Program, Faculty of Medicine, Universitas Sriwijaya , Palembang , Indonesia

Zen Hafy Orcid logo ,
Zen Hafy

Biomedical Doctoral Study Program, Faculty of Medicine, Universitas Sriwijaya , Palembang , Indonesia

Fitri Octaviana Orcid logo ,
Fitri Octaviana

Department of Neurology, Faculty of Medicine, Universitas Indonesia , Jakarta , Indonesia

Diah Widiastuti Orcid logo
Diah Widiastuti

Department of Neurology, Faculty of Medicine, Universitas Sriwijaya , Palembang , Indonesia

Abstract

Aim To examine the association between metabolic syndrome and risk factors in epileptic patients at Dr. Mohammad Hoesin General Hospital in Palembang, Indonesia.
Methods A hospital-based comparative case control research was conducted from July to September 2023. A total of 102 patients in the epilepsy group and 102 in the control group participated in this study. We conducted the data collection approach in three stages: a questionnaire, anthropometric measures and biochemical analysis. 
Results Epilepsy patients were more likely to develop metabolic syndrome than the controls. The epilepsy group exhibited higher triglycerides, fasting blood sugar, and lower high density lipoprotein (HDL) values than the control group. The epilepsy group exhibited sedentary behaviour, while the control group had moderate to intense physical activity (p<0.05). Epilepsy patients who take polytherapy, or several antiepileptic drugs, were 8.43 times more likely to develop metabolic syndrome (OR=8.43; 95%CI=1.45-32.12). Epilepsy patients with body mass index (BMI) >25 had 1.57 times the risk of metabolic syndrome (OR=1.57; 95%CI=1.16-2.34). Epilepsy patients with total cholesterol levels >200 mg/dL have a 5.81-fold higher risk of metabolic syndrome (OR=5.81; 95%CI=1.23-23.32). 
Conclusion Our study found that more than a quarter of epilepsy patients have metabolic syndrome. The main risk factors for metabolic syndrome in epilepsy patients were a sedentary lifestyle, several antiepileptic medications, overweight, and increased total cholesterol levels.

Citation

Funding Statement

No specific funding was received for this study.

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.